Literature DB >> 29622793

cAMP-independent non-pigmentary actions of variant melanocortin 1 receptor: AKT-mediated activation of protective responses to oxidative DNA damage.

María Castejón-Griñán1, Cecilia Herraiz2, Conchi Olivares1, Celia Jiménez-Cervantes1, Jose Carlos García-Borrón1.   

Abstract

The melanocortin 1 receptor gene (MC1R), a well-established melanoma susceptibility gene, regulates the amount and type of melanin pigments formed within epidermal melanocytes. MC1R variants associated with increased melanoma risk promote the production of photosensitizing pheomelanins as opposed to photoprotective eumelanins. Wild-type (WT) MC1R activates DNA repair and antioxidant defenses in a cAMP-dependent fashion. Since melanoma-associated MC1R variants are hypomorphic in cAMP signaling, these non-pigmentary actions are thought to be defective in MC1R-variant human melanoma cells and epidermal melanocytes, consistent with a higher mutation load in MC1R-variant melanomas. We compared induction of antioxidant enzymes and DNA damage responses in melanocytic cells of defined MC1R genotype. Increased expression of catalase (CAT) and superoxide dismutase (SOD) genes following MC1R activation was cAMP-dependent and required a WT MC1R genotype. Conversely, pretreatment of melanocytic cells with an MC1R agonist before an oxidative challenge with Luperox decreased (i) accumulation of 8-oxo-7,8-dihydro-2'-deoxyguanine, a major product of oxidative DNA damage, (ii) phosphorylation of histone H2AX, a marker of DNA double-strand breaks, and (iii) formation of DNA breaks. These responses were comparable in cells WT for MC1R or harboring hypomorphic MC1R variants without detectable cAMP signaling. In MC1R-variant melanocytic cells, the DNA-protective responses were mediated by AKT. Conversely, in MC1R-WT melanocytic cells, high cAMP production downstream of MC1R blocked AKT activation and was responsible for inducing DNA repair. Accordingly, MC1R activation could promote repair of oxidative DNA damage by a cAMP-dependent pathway downstream of WT receptor, or via AKT in cells of variant MC1R genotype.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29622793     DOI: 10.1038/s41388-018-0216-1

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  87 in total

1.  A comprehensive functional analysis of PTEN mutations: implications in tumor- and autism-related syndromes.

Authors:  Isabel Rodríguez-Escudero; María D Oliver; Amparo Andrés-Pons; María Molina; Víctor J Cid; Rafael Pulido
Journal:  Hum Mol Genet       Date:  2011-08-09       Impact factor: 6.150

Review 2.  DNA damage and repair: from molecular mechanisms to health implications.

Authors:  Fabio Altieri; Caterina Grillo; Manola Maceroni; Silvia Chichiarelli
Journal:  Antioxid Redox Signal       Date:  2008-05       Impact factor: 8.401

Review 3.  PARP-1 activation in the ERK signaling pathway.

Authors:  Malka Cohen-Armon
Journal:  Trends Pharmacol Sci       Date:  2007-10-24       Impact factor: 14.819

4.  Ultraviolet B light induces G1 arrest in human melanocytes by prolonged inhibition of retinoblastoma protein phosphorylation associated with long-term expression of the p21Waf-1/SDI-1/Cip-1 protein.

Authors:  E E Medrano; S Im; F Yang; Z A Abdel-Malek
Journal:  Cancer Res       Date:  1995-09-15       Impact factor: 12.701

Review 5.  The genomic landscape of cutaneous melanoma.

Authors:  Tongwu Zhang; Ken Dutton-Regester; Kevin M Brown; Nicholas K Hayward
Journal:  Pigment Cell Melanoma Res       Date:  2016-03-04       Impact factor: 4.693

6.  Melanocortin 1 receptor variants in an Irish population.

Authors:  R Smith; E Healy; S Siddiqui; N Flanagan; P M Steijlen; I Rosdahl; J P Jacques; S Rogers; R Turner; I J Jackson; M A Birch-Machin; J L Rees
Journal:  J Invest Dermatol       Date:  1998-07       Impact factor: 8.551

Review 7.  Extracellular signal-regulated kinases modulate DNA damage response - a contributing factor to using MEK inhibitors in cancer therapy.

Authors:  F Wei; J Yan; D Tang
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

8.  Akt: a double-edged sword in cell proliferation and genome stability.

Authors:  Naihan Xu; Yuanzhi Lao; Yaou Zhang; David A Gillespie
Journal:  J Oncol       Date:  2012-03-15       Impact factor: 4.375

9.  cAMP signaling inhibits radiation-induced ATM phosphorylation leading to the augmentation of apoptosis in human lung cancer cells.

Authors:  Eun-Ah Cho; Eui-Jun Kim; Sahng-June Kwak; Yong-Sung Juhnn
Journal:  Mol Cancer       Date:  2014-02-24       Impact factor: 27.401

10.  An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair/fair skin background.

Authors:  Devarati Mitra; Xi Luo; Ann Morgan; Jin Wang; Mai P Hoang; Jennifer Lo; Candace R Guerrero; Jochen K Lennerz; Martin C Mihm; Jennifer A Wargo; Kathleen C Robinson; Suprabha P Devi; Jillian C Vanover; John A D'Orazio; Martin McMahon; Marcus W Bosenberg; Kevin M Haigis; Daniel A Haber; Yinsheng Wang; David E Fisher
Journal:  Nature       Date:  2012-10-31       Impact factor: 49.962

View more
  10 in total

1.  Cutaneous pharmacologic cAMP induction induces melanization of the skin and improves recovery from ultraviolet injury in melanocortin 1 receptor-intact or heterozygous skin.

Authors:  Robert-Marlo Bautista; Katharine Marie Carter; Stuart Gordon Jarrett; Dana Napier; Kazumasa Wakamatsu; Shosuke Ito; John August D'Orazio
Journal:  Pigment Cell Melanoma Res       Date:  2019-08-24       Impact factor: 4.693

Review 2.  Focus on the Contribution of Oxidative Stress in Skin Aging.

Authors:  Federica Papaccio; Andrea D Arino; Silvia Caputo; Barbara Bellei
Journal:  Antioxidants (Basel)       Date:  2022-06-06

Review 3.  The Emerging Roles and Therapeutic Implications of Epigenetic Modifications in Ovarian Cancer.

Authors:  Yu Wang; Zhao Huang; Bowen Li; Lin Liu; Canhua Huang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-10       Impact factor: 6.055

4.  Sirtuin 1-mediated deacetylation of XPA DNA repair protein enhances its interaction with ATR protein and promotes cAMP-induced DNA repair of UV damage.

Authors:  Stuart G Jarrett; Katharine M Carter; Robert-Marlo Bautista; Daheng He; Chi Wang; John A D'Orazio
Journal:  J Biol Chem       Date:  2018-10-16       Impact factor: 5.486

Review 5.  Targeting GPCRs and Their Signaling as a Therapeutic Option in Melanoma.

Authors:  Jérémy H Raymond; Zackie Aktary; Lionel Larue; Véronique Delmas
Journal:  Cancers (Basel)       Date:  2022-01-29       Impact factor: 6.639

Review 6.  3D Bioprinting: An Enabling Technology to Understand Melanoma.

Authors:  Samantha Fernandes; Cian Vyas; Peggy Lim; Rúben F Pereira; Amaya Virós; Paulo Bártolo
Journal:  Cancers (Basel)       Date:  2022-07-20       Impact factor: 6.575

7.  MGRN1 as a Phenotypic Determinant of Human Melanoma Cells and a Potential Biomarker.

Authors:  Marta Abrisqueta; Sonia Cerdido; José Sánchez-Beltrán; Idoya Martínez-Vicente; Cecilia Herraiz; Ana Lambertos; Conchi Olivares; Arrate Sevilla; Santos Alonso; María Dolores Boyano; José Carlos García-Borrón; Celia Jiménez-Cervantes
Journal:  Life (Basel)       Date:  2022-07-26

8.  Inhibition of non-homologous end joining of gamma ray-induced DNA double-strand breaks by cAMP signaling in lung cancer cells.

Authors:  Sung-Eun Noh; Yong-Sung Juhnn
Journal:  Sci Rep       Date:  2020-09-02       Impact factor: 4.379

9.  Topical MTII Therapy Suppresses Melanoma Through PTEN Upregulation and Cyclooxygenase II Inhibition.

Authors:  Jian-Ching Wu; Han-En Tsai; Yi-Hsiang Hsiao; Ji-Syuan Wu; Chieh-Shan Wu; Ming-Hong Tai
Journal:  Int J Mol Sci       Date:  2020-01-20       Impact factor: 5.923

Review 10.  Behind the Scene: Exploiting MC1R in Skin Cancer Risk and Prevention.

Authors:  Michele Manganelli; Stefania Guida; Anna Ferretta; Giovanni Pellacani; Letizia Porcelli; Amalia Azzariti; Gabriella Guida
Journal:  Genes (Basel)       Date:  2021-07-19       Impact factor: 4.096

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.